Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

159 results
  1. NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007
    ... 3-4. Gangarossa S, Lucini NR. 1993. High-dose intravenous immunoglobulin therapy, blood rheology, and sickle cell anemia. Journal of ... 824. Hamrock D. 2006. Adverse events associated with intravenous immunoglobulin therapy. International Immunopharmacology, 6: 535-542. Hanna K, Poulin- ...
  2. NLM Digital Collections - Anatomy of the immune system immune mechanisms in ITP 
    Publication: Hanover, N.J. : Sandoz Pharmaceuticals, c1988
    Immunoglobulins, Intravenous -- therapeutic use ... Purpura, Thrombocytopenic, Idiopathic -- immunology Purpura, Thrombocytopenic, Idiopathic -- therapy Immunoglobulins, Intravenous -- therapeutic use Peach poster with black and white lettering. ...
  3. NLM Digital Collections - Intravenous immunoglobulin 
    Publication: [Bethesda, Md. : Medical Arts and Photography Branch, National Institutes of Health], 1990
    Immunoglobulins, Intravenous -- therapeutic use ... Intravenous immunoglobulin Immunoglobulins, Intravenous -- therapeutic use Consensus Development Conferences, NIH as Topic Poster with a wide dark blue border on the left and ...
  4. ... Emerg Care 1990 Sep;6(3): 183-5 Intravenous immunoglobulin therapy for prevention of infection in high-risk premature ... Coll Cardiol 1990 Dec;16(7):1535-7. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature ...
  5. ... 1983 Nov 4;18(21):1, 11 TRENDS Intravenous immunoglobulin therapy: new aspects and outlook. Imbach P, et al. ... L Imbach P, Barandun S, Baumgartner C, et al: Intravenous immunoglobulin therapy: new aspects and outlook. Blut 1984 Jun;48( ...
  6. ... 38(10): 1429-46 Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment- ... Bethesda, MD 20892, USA.): Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment- ...
  7. NLM Digital Collections - Eculizumab and efgartigimod for the treatment of myasthenia gravis : effectiveness and value :... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
    ... reduce immunosuppressive therapy, the need for ongoing rescue therapy (intravenous immunoglobulin G (IVIg) or plasma exchange [PE]), or the ... state • Documented diagnosis of thrombotic complications to polyclonal intravenous immunoglobulin (IVIG) therapy in the past • PLEX performed within the last ...
  8. ... AMBULATORY HOME CARE AGENCIES Home health care costs: intravenous immunoglobulin home infusion therapy. Bielory L, et al. Ann Allergy Asthma Immunol ... 85(7):970-5 Home health care costs: intravenous immunoglobulin home infusion therapy. Bielory L, et al. Ann Allergy Asthma Immunol ...
  9. NLM Digital Collections - Mandated benefits 
    Publication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020
    ... including, but not limited to, the use of intravenous immunoglobulin therapy. In Minnesota 2019 MN S.F. 3418 (NS) was ...
  10. NLM Digital Collections - Medical errors and patient safety 
    Publication: [Toronto, Ontario] : Thomson Reuters, 21-December-2020
    ... including, but not limited to, the use of intravenous immunoglobulin therapy. In Michigan 2019 MI H.B. 4449 (NS) ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last